Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
European Urology Oncology|December 30, 2025
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO)Alexander Giesen, Gaëtan Devos, Lorenzo Tosco, et al.
Molecular Cancer Research : MCR|June 22, 2026
ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancerFrancesca Lorenzin, Giulia Fracassi, Federico Vannuccini, et al.
European Urology Open Science|August 18, 2025
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional CohortAlexander Giesen, Daimantas Milonas, Annouschka Laenen, et al.
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
European Urology Open Science|January 16, 2026
Impact of Negative Prostate-specific Membrane Antigen Positron Emission Tomography on the Decision to Perform a Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- to High-risk Prostate Cancer Patients: Results of an International SurveyFabio Zattoni, Pawel Rajwa, Veeru Kasivisvanathan, et al.
European Urology Oncology|October 16, 2023
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European StudyPawel Rajwa, Daniele Robesti, Michael Chaloupka, et al.
European Urology Oncology|September 9, 2023
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging ParametersElio Mazzone, Giorgio Gandaglia, Daniele Robesti, et al.
European Urology Oncology|June 3, 2023
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel ToolGiorgio Gandaglia, Francesco Barletta, Daniele Robesti, et al.
Nature Communications|November 16, 2024
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancerAntti Kiviaho, Sini K Eerola, Heini M L Kallio, et al.
Pageof 3